Login / Signup

Renal Cell Carcinoma Perfusion before and after Radiofrequency Ablation Measured with Dynamic Contrast Enhanced MRI: A Pilot Study.

Tze Min WahSteven SourbronDaniel Jonathan WilsonDerek MageeWalter Martin GregoryPeter John SelbyDavid L Buckley
Published in: Diagnostics (Basel, Switzerland) (2018)
DCE-MRI can detect early treatment effects by measuring RCC perfusion before and after RFA. Perfusion significantly decreases in the zone of ablation, suggesting that it may be useful for the assessment of treatment efficacy. Pre-RFA RCC blood flow may be used to predict RFA treatment time.
Keyphrases
  • radiofrequency ablation
  • contrast enhanced
  • renal cell carcinoma
  • blood flow
  • computed tomography
  • diffusion weighted imaging
  • clinical evaluation